NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
April 18, 2025 — Creative Biolabs offers a complete range of iPSC services for disease research and regenerative medicine, including reprogramming and differentiation. Advanced techniques ensure high-quality iPSC lines tailored to specific research needs, with specialized services like astrocyte differentiation for neurological disease research.
April 17, 2025 — Nutriband CEO Gareth Sheridan named finalist in prestigious EY Entrepreneur of the Year Awards for innovative work in drug delivery technology and opioid abuse prevention. Learn more about Nutriband's AVERSA patch and the impact of entrepreneurship in the life sciences sector.
April 17, 2025 — Aditxt (NASDAQ: ADTX) reveals key findings from ADI-100 preclinical study with Mayo Clinic's Dr. Howe. Learn about the company's focus on accelerating health innovations and developing disruptive solutions for societal challenges.
April 17, 2025 — Kairos Pharma receives funding from the U.S. Department of Defense for biomarker research in non-small cell lung cancer, highlighting the company's commitment to improving outcomes through targeted therapy. ENV105, the lead candidate, is being studied in Phase 1 and 2 trials for lung cancer and prostate cancer, addressing critical unmet medical needs.
April 17, 2025 — Global brain tumor treatment market projected to grow at 7.2% CAGR, reaching $7.15 billion by 2035. Future Market Insights report highlights opportunities for companies like CNS Pharmaceuticals Inc. (NASDAQ: CNSP) to benefit from advancements in immunotherapy and personalized medicine.
April 17, 2025 — Calidi Biotherapeutics receives FDA clearance for CLD-201, a stem cell-based virotherapy targeting solid tumors, offering hope for hard-to-treat cancers. InvestorWire's press release syndication highlights the breakthrough in cancer treatment, emphasizing the importance of communicating such advancements to the investment community.
April 17, 2025 — In a significant development, researchers unveil a plasmonic fidget spinner (P-FS) that revolutionizes bacterial detection with ultra-fast and precise identification. This breakthrough tool has the potential to transform infection management, antibiotic stewardship, and disease surveillance, ultimately saving lives and reducing healthcare costs worldwide.
April 17, 2025 — Learn about the distinguished career and current research focus of Dr. Ghoshal, a renowned healthcare specialist in Neurology. Discover her contributions to the field and the impact of her work on patients with neurodegenerative disorders.
April 16, 2025 — Stonegate Capital Partners updates coverage on Bio-Path Holdings, Inc. for Q4 2024, demonstrating the DNAbilize® platform's potential in obesity and oncology. Learn about the company's breakthrough technology, ongoing clinical trials, strategic partnerships, and strong IP position.
April 16, 2025 — Tonix Pharmaceuticals (NASDAQ: TNXP) to showcase TNX-102 SL for fibromyalgia management at World Vaccine Congress Washington 2025. Company also receives $34 million contract for antiviral development. Exciting advancements in biopharmaceuticals.
April 16, 2025 — CCHR Florida hosts event in Clearwater to advocate for veterans' mental health rights and raise awareness of the dangers of psychiatric drugs. Learn about non-drug alternatives and join the discussion on mental health human rights.
April 16, 2025 — Punyam Academy introduces EFfCI GMP Quality Management System Internal Auditor Training Course, offering certification and practical audit preparation for professionals in the cosmetic industry. Enhance your auditing skills and career with this globally recognized online course.
April 16, 2025 — Artemis Adolescent Healing Center expands its teen treatment services with new dual diagnosis and depression programs, addressing the rising mental health needs of adolescents. The center's comprehensive approach aims to provide specialized care for teens struggling with emotional, psychological, and co-occurring disorders.
April 15, 2025 — Vycor Medical reports 10% revenue growth for 2024, driven by increased US hospital sales. The financial results demonstrate the company's commitment to growth, development, and strategic partnerships. Learn more about the impact of global trade tariffs on the company's operations.
April 15, 2025 — Bluejay (NASDAQ: BJDX) announces agreement with investors to exercise warrants for common stock. Aegis Capital Corp. advises on transaction, resulting in $3.7 million gross proceeds. Company focuses on developing rapid diagnostics for critical care settings.
April 15, 2025 — American Heart Association and Jaguars Foundation collaborate to provide CPR and AED training in Duval County schools, enhancing life-saving skills and advocating for cardiac emergency preparedness. Learn how this initiative is making a positive impact on community health and survival rates.
April 15, 2025 — Dr. Ferhaan Ahmad takes on the role of editor-in-chief at Circulation: Genomic and Precision Medicine, bringing expertise in cardiovascular genomics. His leadership aims to drive scientific advancements in precision medicine, benefiting patients with cardiovascular conditions.
April 15, 2025 — GeoVax Labs, Inc. to discuss BARDA contract termination and latest developments at the Emerging Growth Conference. Learn about the Company's innovative vaccine programs and potential impact on stakeholders' decisions.
April 15, 2025 — Researchers unveil a groundbreaking blood test for early Parkinson's detection, offering hope for timely treatment. Learn more about the study's findings and the potential impact on patients.
April 15, 2025 — Nutriband introduces AVERSA technology to enhance safety of transdermal drugs like fentanyl. Learn about their latest innovation and its potential impact on pharmaceuticals.